Consolidated Condensed Statements of Stockholders’ Deficit (Unaudited) - USD ($) shares in Thousands, $ in Millions	Total	Common Stock	Additional Paid-in Capital	Accumulated Deficit	Accumulated Other Comprehensive Loss
Balance (in shares) at Oct. 31, 2023		988,782
Balance at the beginning of period at Oct. 31, 2023	$ (1,069)	$ 10	$ 1,505	$ (2,361)	$ (223)
Increase (Decrease) in Stockholders' Equity
Net earnings	622			622
Other comprehensive income (loss), net of taxes	(235)				(235)
Comprehensive income	387
Issuance of common stock in connection with employee stock plans and other (in shares)		8,677
Issuance of common stock in connection with employee stock plans and other	$ (76)		(76)
Repurchases of common stock (in shares)	(17,100)	(17,062)
Repurchases of common stock (Note 10)	$ (514)		(27)	(487)
Cash dividends	(545)			(545)
Stock-based compensation expense	177		177
Balance (in shares) at Jan. 31, 2024		980,397
Balance at the end of period at Jan. 31, 2024	$ (1,640)	$ 10	1,579	(2,771)	(458)
Balance (in shares) at Oct. 31, 2024	939,000	938,989
Balance at the beginning of period at Oct. 31, 2024	$ (1,323)	$ 9	1,778	(2,676)	(434)
Increase (Decrease) in Stockholders' Equity
Net earnings	565			565
Other comprehensive income (loss), net of taxes	230				230
Comprehensive income	795
Issuance of common stock in connection with employee stock plans and other (in shares)		8,405
Issuance of common stock in connection with employee stock plans and other	$ (92)		(92)
Repurchases of common stock (in shares)	(2,700)	(2,734)
Repurchases of common stock (Note 10)	$ (97)		(4)	(93)
Cash dividends	(547)			(547)
Stock-based compensation expense	$ 192		192
Balance (in shares) at Jan. 31, 2025	945,000	944,660
Balance at the end of period at Jan. 31, 2025	$ (1,072)	$ 9	$ 1,874	$ (2,751)	$ (204)